Lilly: Eli Lilly Stock: New Weight Loss Pill Challenges Competitors
Eli Lilly's recent announcement regarding their experimental weight loss pill Orforglipron has sent significant ripples through the pharmaceutical market. The company revealed compelling Phase 3 cl...
Read full article »
Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.
Read more